The groundbreaking therapy of tirzepatide peptide represents a significant advance in the handling of the condition. Distinct from existing drugs, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide253019.theisblog.com/42443804/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment